A Multi-institutional Review of Management and Outcomes of Subtypes of Urothelial Carcinoma of Bladder.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
研究概览
简要总结
This retrospective, observational study evaluates the management and oncological outcomes of adult patients with subtype urothelial carcinoma of the bladder treated at Tata Memorial Centre, Mumbai after 1 January 2016. Patients with histologically confirmed variant subtypes of urothelial carcinoma will be included.
Clinical, pathological, treatment, and outcome data will be collected from institutional electronic medical records. Outcomes assessed include overall survival, disease-free survival, and recurrence patterns. Subgroup analyses will evaluate outcomes by histological subtype, treatment modality, and use of neoadjuvant chemotherapy. This study aims to enhance understanding of disease behavior and outcomes in subtype urothelial carcinoma of the bladder and support evidence-based management strategies.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients treated at TMC, Mumbai after 1/1/2016 Age is more than 18 Urothelial carcinoma of bladder with one or more of the following subtype(s): Micropapillary Squamous differentiation Glandular differentiation Sarcomatoid Small cell/ Neuroendocrine Plasmacytoid Nested Tubular and microcystic Lymphoepithelioma-like Giant cell Clear cell Poorly differentiated.
排除标准
- •Patients with pure urothelial carcinoma, lymphoma, and other rare pathology will be excluded.
- •Patients with presence of metastasis to the bladder from other primary organs will be excluded.
研究者
Dr GAGAN PRAKASH
Tata Memorial Hospital